Compounds > oxazoles
Page last updated: 2024-08-21

oxazoles and virginiamycin

oxazoles has been researched along with virginiamycin in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (46.15)18.2507
2000's7 (53.85)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appelbaum, PC; Jacobs, MR; Spangler, SK1
Drenning, SD; Mulazimoglu, L; Yu, VL1
Peters, G; von Eiff, C1
Fresnadillo, MJ; García-Rodríguez, JA; García-Sánchez, E; García-Sánchez, JE; Montes Martínez, I; Trujillano-Martín, I1
Chandrasekar, PH; Clark, NM; Kauffman, CA; McNeil, SA1
Grucz, RG; Hershberger, E; Moldovan, T; Rybak, MJ1
MacConnachie, AM1
Lundstrom, TS; Sobel, JD1
Betriu, C; Boloix, A; Culebras, E; Gómez, M; Palau, ML; Picazo, JJ; Redondo, M; Sánchez, A1
Martín, IT; Martínez, MJ; Rincón, MR; Sáenz, NG; Sánchez, EG; Sánchez, JE1
Flanagan, PG; Penrose-Stevens, A; Pitman, I; Simpson, BA; Tan, TY1
Bhateja, P; Bhatnagar, PK; Fatma, T; Khan, S; Mathur, T; Pandya, M; Rattan, A; Singhal, S; Upadhyay, DJ1

Reviews

2 review(s) available for oxazoles and virginiamycin

ArticleYear
New antibiotics for gram positive infections: linezolid and combination quinapristin/dalfopristin.
    Intensive & critical care nursing, 1999, Volume: 15, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Drug Prescriptions; Drug Resistance, Microbial; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Safety; Virginiamycin

1999
Antibiotics for gram-positive bacterial infections. Vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid.
    Infectious disease clinics of North America, 2000, Volume: 14, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazoles; Oxazolidinones; Teicoplanin; Vancomycin; Virginiamycin

2000

Other Studies

11 other study(ies) available for oxazoles and virginiamycin

ArticleYear
Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Acetamides; Amino Acid Sequence; Anti-Bacterial Agents; Cephalosporins; Linezolid; Microbial Sensitivity Tests; Molecular Sequence Data; Oxazoles; Oxazolidinones; Penicillin Resistance; Streptococcus pneumoniae; Virginiamycin

1996
In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Synergism; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Naphthyridines; Oxazoles; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Virginiamycin

1996
Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 43, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Virginiamycin

1999
In vitro activities of five new antimicrobial agents against Brucella melitensis.
    International journal of antimicrobial agents, 1999, Volume: 12, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Brucella melitensis; Humans; Linezolid; Microbial Sensitivity Tests; Mupirocin; Oxazoles; Oxazolidinones; Rifabutin; Virginiamycin

1999
Battling drug resistance.
    Journal of the American Dental Association (1939), 1999, Volume: 130, Issue:11

    Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Oxazoles; Oxazolidinones; Streptococcal Infections; Streptococcus pyogenes; Vancomycin Resistance; Virginiamycin

1999
Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Bone Marrow Transplantation; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus faecium; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Leukemia, Myeloid, Acute; Linezolid; Male; Middle Aged; Oxazoles; Oxazolidinones; Postoperative Complications; Treatment Failure; Treatment Outcome; Vancomycin Resistance; Virginiamycin

2000
In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against Staphylococci and Enterococci, including vancomycin- intermediate and -resistant strains.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple; Enterococcus; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Staphylococcus; Time Factors; Vancomycin; Virginiamycin

2000
Comparative in vitro activities of linezolid, quinupristin-dalfopristin, moxifloxacin, and trovafloxacin against erythromycin-susceptible and -resistant streptococci.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:7

    Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Microbial; Drug Therapy, Combination; Erythromycin; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Oxazoles; Oxazolidinones; Quinolines; Streptococcus; Virginiamycin

2000
Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones.
    The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:2

    Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Mupirocin; Oxazoles; Stomach; Virginiamycin

2000
Treatment of a vancomycin-resistant Enterococcus faecium ventricular drain infection with quinupristin/dalfopristin and review of the literature.
    The Journal of infection, 2000, Volume: 41, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus faecium; Fatal Outcome; Female; Gram-Positive Bacterial Infections; Humans; Hydrocephalus; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Linezolid; Middle Aged; Oxazoles; Oxazolidinones; Subarachnoid Hemorrhage; Tomography, X-Ray Computed; Vancomycin; Ventriculoperitoneal Shunt; Virginiamycin

2000
Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces.
    Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:4

    Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Dose-Response Relationship, Drug; Furans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Plastics; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin; Virginiamycin

2008